GABITRIL

Product NDC
63459-404
11-digit product format
634590404
Labeler code
63459
Product ID
63459-404_cdd94737-c30c-4035-8809-78c0ba68b88d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tiagabine Hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Cephalon, LLC
Application
NDA020646
Marketing category
NDA
Marketing start
2001-04-01
Marketing end
0000-00-00
Substance
TIAGABINE HYDROCHLORIDE
Active strength
4 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
unfinished productproduct63459-404UNFINISHEDActive or certified unfinished drug listing2026-11-19
unfinished packagepackage63459-40463459-404-99UNFINISHEDActive or certified unfinished drug listing2026-11-19
excluded productproduct63459-404DDiscontinued by firm2026-11-19
excluded packagepackage63459-40463459-404-01DDiscontinued by firm2026-11-19
excluded packagepackage63459-40463459-404-30DDiscontinued by firm2026-11-19

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 70 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusArchiveSnapshotSource SHA-256
2025-12-14 21:27 UTC · source 2025-12-05unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipa6255e0c9aa5…a0211a219f2e…
2025-12-14 21:27 UTC · source 2025-12-05unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipa6255e0c9aa5…a0211a219f2e…
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipf5e01cc5f278…a2eaf40c39c3…
2025-08-26 23:59 UTC · source 2025-08-26unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip1d862106b807…00c93037cd84…
2025-08-26 23:59 UTC · source 2025-08-26unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip1d862106b807…00c93037cd84…
2025-05-15 14:59 UTC · source 2025-05-14unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip390b4c401c3f…2c692c2daee3…
2025-05-15 14:59 UTC · source 2025-05-14unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip390b4c401c3f…2c692c2daee3…
2025-04-01 07:37 UTC · source 2025-03-31unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipe30019b0c005…a3f0b14938b7…
2025-04-01 07:37 UTC · source 2025-03-31unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipe30019b0c005…a3f0b14938b7…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zip2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zip2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zip2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipcdf11ea48f46…ba0047e9e063…
2025-03-01 13:19 UTC · source 2025-02-28unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipbbbc9f937eca…946b9c97cf81…
2025-03-01 13:19 UTC · source 2025-02-28unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipbbbc9f937eca…946b9c97cf81…
2025-02-27 05:24 UTC · source 2025-02-26unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipf268b84574a6…26285f5ac5df…
2025-02-27 05:24 UTC · source 2025-02-26unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipf268b84574a6…26285f5ac5df…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zip302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zip302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zip302b2466d912…e7b80fea0513…
2025-02-01 13:13 UTC · source 2025-01-31unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipf764e8902f78…92046438deef…
2025-02-01 13:13 UTC · source 2025-01-31unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zipf764e8902f78…92046438deef…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmexcluded / ndc_excluded.ziped331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.ziped331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.ziped331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-17unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip68b1e3bced9e…98a755eb8bc6…
2025-01-20 13:05 UTC · source 2025-01-17unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip68b1e3bced9e…98a755eb8bc6…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zip0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zip0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zip0efc9e666f02…f202fb6c5f17…
2024-11-29 20:42 UTC · source 2024-11-29unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip05c55d027831…ca05dca9dc4c…
2024-11-29 20:42 UTC · source 2024-11-29unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip05c55d027831…ca05dca9dc4c…
2024-11-09 02:36 UTC · source 2024-11-08unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip48b4f40e6753…c7c7a00d2afa…
2024-11-09 02:36 UTC · source 2024-11-08unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip48b4f40e6753…c7c7a00d2afa…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zipad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zipad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zipad56d346431e…cc804d4bbf1e…
2024-10-09 02:27 UTC · source 2024-10-08unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip27f29a85d7e4…1372111e901f…
2024-10-09 02:27 UTC · source 2024-10-08unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip27f29a85d7e4…1372111e901f…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zip367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zip367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zip367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09unfinished productproductUNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip8d62ce987f31…9fe9ef23e30d…
2024-07-10 04:00 UTC · source 2024-07-09unfinished packagepackage63459-404-99UNFINISHEDActive or certified unfinished drug listingunfinished / ndc_unfinished.zip8d62ce987f31…9fe9ef23e30d…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firmexcluded / ndc_excluded.zip557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage63459-404-01DDiscontinued by firmexcluded / ndc_excluded.zip557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage63459-404-30DDiscontinued by firmexcluded / ndc_excluded.zip557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 8 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020646-001GABITRILTIAGABINE HYDROCHLORIDE4MGTABLET / ORALABRLD, RS1997-09-30
N020646-002GABITRILTIAGABINE HYDROCHLORIDE12MGTABLET / ORALABRLD1997-09-30
N020646-003GABITRILTIAGABINE HYDROCHLORIDE16MGTABLET / ORALABRLD1997-09-30
N020646-004GABITRILTIAGABINE HYDROCHLORIDE20MGTABLET / ORAL1997-09-30
N020646-005GABITRILTIAGABINE HYDROCHLORIDE2MGTABLET / ORALABRLD1999-04-16
N020646-006GABITRILTIAGABINE HYDROCHLORIDE6MGTABLET / ORAL2005-11-29
N020646-007GABITRILTIAGABINE HYDROCHLORIDE8MGTABLET / ORAL2005-11-29
N020646-008GABITRILTIAGABINE HYDROCHLORIDE10MGTABLET / ORAL2005-11-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
N020646-001AB
N020646-002AB
N020646-003AB
N020646-005AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 9 · 360 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N020646-001GABITRIL4MGTABLET / ORALABRLD, RS1997-09-30d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-002GABITRIL12MGTABLET / ORALABRLD1997-09-30d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-003GABITRIL16MGTABLET / ORALABRLD1997-09-30d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-004GABITRIL20MGTABLET / ORAL1997-09-30d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-005GABITRIL2MGTABLET / ORALABRLD1999-04-16d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-006GABITRIL6MGTABLET / ORAL2005-11-29d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-007GABITRIL8MGTABLET / ORAL2005-11-29d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-008GABITRIL10MGTABLET / ORAL2005-11-29d4dbc9d85df4…
2026-10-15 13:18:302026-09N020646-001GABITRIL4MGTABLET / ORALABRLD, RS1997-09-30c2088c7a36db…
2026-10-15 13:18:302026-09N020646-002GABITRIL12MGTABLET / ORALABRLD1997-09-30c2088c7a36db…
2026-10-15 13:18:302026-09N020646-003GABITRIL16MGTABLET / ORALABRLD1997-09-30c2088c7a36db…
2026-10-15 13:18:302026-09N020646-004GABITRIL20MGTABLET / ORAL1997-09-30c2088c7a36db…
2026-10-15 13:18:302026-09N020646-005GABITRIL2MGTABLET / ORALABRLD1999-04-16c2088c7a36db…
2026-10-15 13:18:302026-09N020646-006GABITRIL6MGTABLET / ORAL2005-11-29c2088c7a36db…
2026-10-15 13:18:302026-09N020646-007GABITRIL8MGTABLET / ORAL2005-11-29c2088c7a36db…
2026-10-15 13:18:302026-09N020646-008GABITRIL10MGTABLET / ORAL2005-11-29c2088c7a36db…
2026-09-14 22:38:342026-08N020646-001GABITRIL4MGTABLET / ORALABRLD, RS1997-09-3084e616aacf4f…
2026-09-14 22:38:342026-08N020646-002GABITRIL12MGTABLET / ORALABRLD1997-09-3084e616aacf4f…
2026-09-14 22:38:342026-08N020646-003GABITRIL16MGTABLET / ORALABRLD1997-09-3084e616aacf4f…
2026-09-14 22:38:342026-08N020646-004GABITRIL20MGTABLET / ORAL1997-09-3084e616aacf4f…
2026-09-14 22:38:342026-08N020646-005GABITRIL2MGTABLET / ORALABRLD1999-04-1684e616aacf4f…
2026-09-14 22:38:342026-08N020646-006GABITRIL6MGTABLET / ORAL2005-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N020646-007GABITRIL8MGTABLET / ORAL2005-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N020646-008GABITRIL10MGTABLET / ORAL2005-11-2984e616aacf4f…
2026-08-18 06:07:402026-07N020646-001GABITRIL4MGTABLET / ORALABRLD, RS1997-09-30caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-002GABITRIL12MGTABLET / ORALABRLD1997-09-30caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-003GABITRIL16MGTABLET / ORALABRLD1997-09-30caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-004GABITRIL20MGTABLET / ORAL1997-09-30caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-005GABITRIL2MGTABLET / ORALABRLD1999-04-16caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-006GABITRIL6MGTABLET / ORAL2005-11-29caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-007GABITRIL8MGTABLET / ORAL2005-11-29caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-008GABITRIL10MGTABLET / ORAL2005-11-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020646-001GABITRIL4MGTABLET / ORALABRLD, RS1997-09-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-002GABITRIL12MGTABLET / ORALABRLD1997-09-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-003GABITRIL16MGTABLET / ORALABRLD1997-09-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-004GABITRIL20MGTABLET / ORAL1997-09-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-005GABITRIL2MGTABLET / ORALABRLD1999-04-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-006GABITRIL6MGTABLET / ORAL2005-11-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-007GABITRIL8MGTABLET / ORAL2005-11-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-008GABITRIL10MGTABLET / ORAL2005-11-29011fe1cb6892…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 180 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N020646-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-003AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020646-005AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09N020646-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09N020646-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09N020646-003AB1c2088c7a36db…
2026-10-15 13:18:302026-09N020646-005AB1c2088c7a36db…
2026-09-14 22:38:342026-08N020646-001AB184e616aacf4f…
2026-09-14 22:38:342026-08N020646-002AB184e616aacf4f…
2026-09-14 22:38:342026-08N020646-003AB184e616aacf4f…
2026-09-14 22:38:342026-08N020646-005AB184e616aacf4f…
2026-08-18 06:07:402026-07N020646-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N020646-005AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020646-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020646-005AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020646-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020646-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020646-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020646-005AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020646-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020646-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020646-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020646-005AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020646-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020646-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020646-003AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020646-005AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020646-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020646-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020646-003AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020646-005AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020646-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020646-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020646-003AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020646-005AB103ed91905a0d…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
No
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TIAGABINE HYDROCHLORIDE4 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0b72e14f-1cc2-c389-aef5-c9c0a7b93fb8Product name420220613
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63459-404-01EA - Each63459-404ebb170a6-844c-4619-b475-90c2f63d6f2c12013-02-11
63459-404-30EA - Each63459-4040b92a604-7cc7-4d7f-9496-83e06eacf8a512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TIAGABINE HYDROCHLORIDEACTIVE INGREDIENTDQH6T6D8OYGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
TIAGABINEACTIVE MOIETYZ80I64HMNPGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
ASCORBIC ACIDINACTIVE INGREDIENTPQ6CK8PD0RGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
CROSPOVIDONEINACTIVE INGREDIENT68401960MKGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
HYDROGENATED SOYBEAN OILINACTIVE INGREDIENTA2M91M918CGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED]15
TIAGABINE HYDROCHLORIDEACTIVE INGREDIENTDQH6T6D8OYGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
tiagabineACTIVE MOIETYZ80I64HMNPGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
ASCORBIC ACIDINACTIVE INGREDIENTPQ6CK8PD0RGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
LACTOSEINACTIVE INGREDIENTJ2B2A4N98GGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPGABITRIL (TIAGABINE HYDROCHLORIDE) TABLET [CARILION MATERIALS MANAGEMENT]2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1299978Gabitril 4 MG Oral TabletPSN72b7f357-8827-4a8b-b55a-01fbce47ae803
1299917tiaGABine HCl 4 MG Oral TabletPSN72b7f357-8827-4a8b-b55a-01fbce47ae803
1299978tiagabine hydrochloride 4 MG Oral Tablet [Gabitril]SBD72b7f357-8827-4a8b-b55a-01fbce47ae803
1299917tiagabine hydrochloride 4 MG Oral TabletSCD72b7f357-8827-4a8b-b55a-01fbce47ae803
1299978Gabitril 4 MG Oral TabletSY72b7f357-8827-4a8b-b55a-01fbce47ae803

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
63459-404-306345904043030 TABLET, FILM COATED in 1 BOTTLE (63459-404-30) 2010-02-080000-00-00NoNoCurrent
63459-404-9963459040499122881 TABLET, FILM COATED in 1 DRUM (63459-404-99)08-FEB-10Current